Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Correction: Stabilization Notice: Pre-Stab Notice CLARIANE SE
-
ContentCon 2026: Every Brand Now Has Two Audiences, Humans and Agents
-
Generate Biomedicines Inc. to Participate in September Investor Conferences
-
Lantronix CEO to Participate in Upcoming Investor and Industry Events
-
Robinson Unmanned R44 AIRTRUCK Demonstrates Offshore Cargo Capabilities at Acadiana Regional Airport in Louisiana
-
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
-
4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics
-
Microchip’s 1.2V Clock Buffers Link Latest SoCs and FPGAs with Higher Voltage Components
-
IREN’s 2GW Sweetwater Hub Included as Base Load in ERCOT Batch Zero
-
Invivyd to Participate in Upcoming September Investor Conferences
-
BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer
-
American Fusion Inc. (OTCQB: AMFN) Expands Intellectual Property Portfolio to 130 U.S. Patent Applications and Provides National Stock Exchange Uplisting and Capital Markets Update
-
Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program
-
Del Taco Celebrates #1 Fast Food Honors With Free Tacos in Port St. Lucie
-
Lightbridge Letter to Shareholders Outlines Expedited Pathway to Bring Lightbridge Fuel™ to Commercial Reactors
-
Silicon Motion to Attend Upcoming Investor Conferences
-
Lahontan Strengthens Technical, Engineering, and Business Development Team
-
NovaBridge Appoints Martin Dewhurst to Board of Directors as an Independent Director
-
CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
-
X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
-
CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
-
G3 Goldfields Provides Update on Listing
-
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
-
Phoenix Metals Receives Amended Exploration Permit and Accelerates Phase 1 Drill Program at Greenwood
-
Rigetti Signs Definitive Agreement for $100M with U.S. Government to Accelerate R&D for Superconducting Quantum Computing
-
Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer
-
Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis
-
BrainChild Bio Closes $116 Million Series A Financing
-
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
-
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
-
NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor
-
BrewDog Roars into Rugby with Five-Year Leicester Tigers Partnership, Bringing Punk Energy to Welford Road
-
Erasca to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
-
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
-
Beamr and VAST Data Partner to AI-enhance and Monetize Video Archives with NVIDIA
-
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
-
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences
-
DraftKings Extends Agreement with IC360 to Enhance Integrity Monitoring and Combat Athlete Harassment Across Sportsbook and Prediction Market Platforms
-
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
-
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
-
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
-
LiveU, AP bring new connectivity, workflow tech to global newsgathering, deploying largest LU900Q fleet worldwide
-
Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics
-
Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
-
CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
-
ABM Reports Fiscal Third Quarter 2026 Results
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
